drugset / Trial / NCT04408586
Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker
RandomizedParallel-groupDouble-blindTreatment
Summary
Researchers are assessing the effects of weight loss medication vs a placebo among participants provided with a wearable activity tracker, digital wellness devices and lifestyle recommendations.
Timeline
- Start
- 2020-06-03
- Primary completion
- 2022-06-13
- Completion
- 2022-10-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Phentermine | Small molecule | 7.5 mg | — |
| Comparator | Topiramate | Small molecule | 46 mg | — |